Inventor · disambiguated record
Christopher Blackburn
Also filed as: BLACKBURN CHRISTOPHER · BLACKBURN CHRISTOPHER PAUL
18 granted patents·9 pending applications·152 citations·filing 1987–2018
94Inventor score
Files withMILLENNIUM PHARM INC11BLACKBURN CHRISTOPHER8ZOLO SOLUTIONS INC4ORE PHARMACEUTICALS INC2ABBOTT LAB1
Top patents by PatentIndex Score
27 records- 0195US8471026B2Substituted hydroxamic acids and uses thereofBLACKBURN CHRISTOPHER·Filed 2011·Granted Jun 25, 2013·49 cites·19 claims
- 0291US7935694B2Lactam compounds useful as protein kinase inhibitorsMILLENNIUM PHARM INC·Filed 2008·Granted May 3, 2011·8 cites·22 claims
- 0390US10124940B2Systems, methods, and devices for dispensing one or more substancesZOLO SOLUTIONS INC·Filed 2015·Granted Nov 13, 2018·11 cites·20 claims
- 0490US9870450B2Drug delivery regulatorZOLO SOLUTIONS INC·Filed 2013·Granted Jan 16, 2018·25 cites·29 claims
- 0590US9382197B2Substituted hydroxamic acids and uses thereofMILLENNIUM PHARM INC·Filed 2013·Granted Jul 5, 2016·7 cites·24 claims
- 0690US7459448B2Lactam compounds useful as protein kinase inhibitorsMILLENNIUM PHARM INC·Filed 2005·Granted Dec 2, 2008·8 cites·22 claims
- 0785US9096518B2Substituted hydroxamic acids and uses thereofBLACKBURN CHRISTOPHER·Filed 2010·Granted Aug 4, 2015·10 cites·28 claims
- 0883US8546588B2Substituted hydroxamic acids and uses thereofBLACKBURN CHRISTOPHER·Filed 2011·Granted Oct 1, 2013·7 cites·19 claims
- 0983US7790719B2Modulators of melanocortin receptorORE PHARMACEUTICALS INC·Filed 2007·Granted Sep 7, 2010·7 cites·18 claims
- 1080US8624040B2Substituted hydroxamic acids and uses thereofBLACKBURN CHRISTOPHER·Filed 2010·Granted Jan 7, 2014·5 cites·19 claims
- 1179US8952163B2Substituted hydroxamic acids and uses thereofMILLENNIUM PHARM INC·Filed 2013·Granted Feb 10, 2015·3 cites·12 claims
- 1271US6921821B2Antagonists of melanin concentrating hormone receptorABBOTT LAB·Filed 2003·Granted Jul 26, 2005·7 cites·23 claims
- 1368US9249142B2Substituted hydroxamic acids and uses thereofMILLENNIUM PHARM INC·Filed 2014·Granted Feb 2, 2016·0 cites·10 claims
- 1464US7365070B2Modulators of melanocortin receptorORE PHARMACEUTICALS INC·Filed 2003·Granted Apr 29, 2008·2 cites·21 claims
- 1560US9227951B2Substituted hydroxamic acids and uses thereofMILLENNIUM PHARM INC·Filed 2013·Granted Jan 5, 2016·0 cites·20 claims
- 1660US2014243335A1Substituted hydoxamic acids and uses thereofBLACKBURN CHRISTOPHER·Filed 2014·Application pending·0 cites
- 1759US2015175614A1Substituted hydroxamic acids and uses thereofMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 1859US2012178739A1Lactam compounds useful as protein kinase inhibitorsBLACKBURN CHRISTOPHER·Filed 2012·Application pending·0 cites
- 1958US2014329836A1Substituted hydroxamic acids and uses thereofMILLENNIUM PHARM INC·Filed 2013·Application pending·0 cites
- 2058US2019084737A1Systems, methods, and devices for dispensing one or more substancesZOLO SOLUTIONS INC·Filed 2018·Application pending·0 cites
- 2155US2018092697A1Drug delivery regulatorZOLO SOLUTIONS INC·Filed 2017·Application pending·0 cites
- 2252US2011039820A1Lactam compounds useful as protein kinase inhibitorsMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
- 2352US2012015943A1Substituted hydroxamic acids and uses thereofBLACKBURN CHRISTOPHER·Filed 2011·Application pending·0 cites
- 2451US2011212969A1Substituted hydroxamic acids and uses thereofMILLENNIUM PHARM INC·Filed 2011·Application pending·0 cites
- 2545US8946223B2Substituted hydroxamic acids and uses thereofBLACKBURN CHRISTOPHER·Filed 2011·Granted Feb 3, 2015·0 cites·28 claims
- 2644US9321731B2Substituted hydroxamic acids and uses thereofMILLENNIUM PHARM INC·Filed 2015·Granted Apr 26, 2016·0 cites·12 claims
- 2731US4838659ALiquid crystal displays and fluorescent dyes for use thereinGEN ELECTRIC CO PLC·Filed 1987·Granted Jun 13, 1989·3 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Blackburn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →